Persist AI Overview
- Year Founded
-
2022

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Early Stage VC
- Investors
-
9
Persist AI General Information
Description
Developer of AI-enabled cloud formulations intended to accelerate drug development and improve patient lives. The company focuses on using artificial intelligence-driven automation technologies such as automated drug release testing, high-throughput formulation screening, and method transfer and manufacturing scale-up, enabling drug manufacturers to speed up drug formulation.
Contact Information
Website
www.persist-ai.comCorporate Office
- 890 Embarcadero Drive
- CoLaborator Space
- West Sacramento, CA 95605
- United States
Corporate Office
- 890 Embarcadero Drive
- CoLaborator Space
- West Sacramento, CA 95605
- United States
Persist AI Timeline
Persist AI Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Early Stage VC | 24-Dec-2024 | Completed | Generating Revenue | |||
5. Seed Round | 16-Aug-2023 | Completed | Generating Revenue | |||
4. Early Stage VC (Series A) | Cancelled | Generating Revenue | ||||
3. Accelerator/Incubator | 28-Jul-2023 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 24-Apr-2023 | $500K | $4.67M | Completed | Generating Revenue | |
1. Seed Round | 15-Dec-2022 | $4.17M | $4.17M | Completed | Generating Revenue |
Persist AI Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-3 | ||||||||
Seed-2 | ||||||||
Seed-1 | 2,851,392 | $0.000010 | $1.15 | $1.15 | 1x | $1.15 | 16.35% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Persist AI Comparisons
Industry
Financing
Details
Persist AI Competitors (2)
One of Persist AI’s 2 competitors is InnoCore Pharmaceuticals, a Corporation company based in Groningen, Netherlands.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
InnoCore Pharmaceuticals | Corporation | Groningen, Netherlands | ||||
Evonik Industries | Formerly PE-Backed | Essen, Germany |
Persist AI Signals
Persist AI Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Good AI Capital | Venture Capital | Minority | ||
Fellows Fund | Venture Capital | Minority | ||
Jovono | Venture Capital | Minority | ||
Pioneer Fund | Venture Capital | Minority | ||
National IT Industry Promotion Agency | Government |
Persist AI FAQs
-
When was Persist AI founded?
Persist AI was founded in 2022.
-
Where is Persist AI headquartered?
Persist AI is headquartered in West Sacramento, CA.
-
What is the size of Persist AI?
Persist AI has 10 total employees.
-
What industry is Persist AI in?
Persist AI’s primary industry is Drug Discovery.
-
Is Persist AI a private or public company?
Persist AI is a Private company.
-
What is Persist AI’s current revenue?
The current revenue for Persist AI is
. -
How much funding has Persist AI raised over time?
Persist AI has raised $8.67M.
-
Who are Persist AI’s investors?
Good AI Capital, Fellows Fund, Jovono, Pioneer Fund, and National IT Industry Promotion Agency are 5 of 9 investors who have invested in Persist AI.
-
Who are Persist AI’s competitors?
InnoCore Pharmaceuticals and Evonik Industries are competitors of Persist AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »